Insider's View

Beyond Resilience: Preventing Burnout in Blood Banking and Biotherapies


"Burnout is a problem of the workplace, not the worker.” - Jonathan Malesic

Burnout has become a familiar topic across health care, and the field of transfusion medicine and biotherapies is not immune. Professionals in our community work in environments where accuracy is essential, patient needs can change within minutes and services must remain available around the clock. At the same time, many organizations in our field face staffing shortages, increasing workloads, expanding regulatory requirements and growing technical complexity.

The traditional response to burnout often focuses on the individual. Employees may be encouraged to exercise, practice mindfulness, improve sleep, use employee assistance programs or develop greater resilience. These strategies can be valuable. However, they address only part of the problem. When burnout is driven by persistent workplace conditions, asking employees to become more resilient does little to change the conditions producing the exhaustion. Preventing burnout in transfusion medicine and biotherapies therefore requires looking beyond individual resilience and examining how our systems are designed. 

Log in to read the full article.

This article is reserved for AABB members.
Please log in or join AABB to continue reading.

Insider's View

By Edward Griffin MBA, MS, MLS(ASCP)SBB, CLS, CQA(ASQ), PMP, Contributing Writer

September 2026

September 2026 View Issue


Find More News

transfusion journal

Transfusion Journal

Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.

Learn More About Transfusion Journal
CellSource

AN UPDATE ON THE LATEST BIOTHERAPIES NEWS

Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.

Read and Subscribe Today

CONTACT US

To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.

CONNECT WITH US

AABB News

President

Jose Cancelas, MD, PhD, CABP

Chief Executive Officer

Debra Ben Avram, FASAE, CAE

Chief Communications and Engagement Officer

Julia Zimmerman

Director of Marketing and Communications

Jay Lewis, MPH

Managing Editor

Kendra Y. Mims, MFA

Senior Communications Manager

Drew Case

AABB News

(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.

AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.

+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.

Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.

2025 APEX Awards for Publication Excellence